These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 10223777)

  • 1. Pharmacokinetics of metoprolol enantiomers in Chinese subjects of major CYP2D6 genotypes.
    Huang J; Chuang SK; Cheng CL; Lai ML
    Clin Pharmacol Ther; 1999 Apr; 65(4):402-7. PubMed ID: 10223777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on genotype and phenotype of novel CYP2D6 variants using pharmacokinetic and pharmacodynamic models with metoprolol as a substrate drug.
    Qian J; Xu T; Pan P; Sun W; Hu G; Cai J
    Pharmacogenomics J; 2024 Apr; 24(3):13. PubMed ID: 38637522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine.
    Wang Z; Gao Y; Ji X; Wu T; Pu L; Qiu W
    J Clin Pharmacol; 2024 May; 64(5):601-608. PubMed ID: 38059315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate.
    Hamadeh IS; Langaee TY; Dwivedi R; Garcia S; Burkley BM; Skaar TC; Chapman AB; Gums JG; Turner ST; Gong Y; Cooper-DeHoff RM; Johnson JA
    Clin Pharmacol Ther; 2014 Aug; 96(2):175-81. PubMed ID: 24637943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrimetric Validation of Solanidine as Dietary-Derived CYP2D6 Activity Marker In Vivo.
    Müller JP; Sarömba J; Ziegler P; Tremmel R; Rengelshausen J; Schaeffeler E; Just KS; Schwab M; Kraus T; Stingl JC
    Clin Pharmacol Ther; 2024 Feb; 115(2):309-317. PubMed ID: 37971251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of
    Gao X; Wang H; Chen H
    Pharmacogenomics; 2024 May; ():1-9. PubMed ID: 29095089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-Based Inactivation of CYP2D6 by Phellopterin and Related Drug-Drug Interaction with Metoprolol.
    Cheng Z; He Y; Chen Y; Zhao G; Liu Y; Zhang J; Li X; Ran G; Zhang Q; Peng Y; Li W; Zheng J
    J Agric Food Chem; 2024 Jan; 72(3):1745-1755. PubMed ID: 38214270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of amiodarone use on metoprolol concentrations, α-OH-metoprolol concentrations, metoprolol dosing and heart rate: A cross-sectional study.
    Robert S; Pilon MO; Oussaïd E; Meloche M; Leclair G; Jutras M; Gaulin MJ; Mongrain I; Busseuil D; Tardif JC; Dubé MP; de Denus S
    Pharmacol Res Perspect; 2023 Oct; 11(5):e01137. PubMed ID: 37732835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects.
    Damy T; Pousset F; Caplain H; Hulot JS; Lechat P
    Fundam Clin Pharmacol; 2004 Feb; 18(1):113-23. PubMed ID: 14748763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study.
    Rau T; Wuttke H; Michels LM; Werner U; Bergmann K; Kreft M; Fromm MF; Eschenhagen T
    Clin Pharmacol Ther; 2009 Mar; 85(3):269-72. PubMed ID: 19037197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
    Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very important pharmacogenetic variants landscape and potential clinical relevance in the Zhuang population from Yunnan province.
    Li Y; Chang Y; Yan Y; Ma X; Zhou W; Zhang H; Guo J; Wei J; Jin T
    Sci Rep; 2024 Mar; 14(1):7495. PubMed ID: 38553524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Beta Blocker Therapy: A Comprehensive Review of Development and Genetic Variation to Guide Precision-Based Therapy in Children, Adolescents, and Young Adults.
    Walton M; Wagner JB
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes.
    Lee CM; Kang P; Cho CK; Park HJ; Lee YJ; Bae JW; Choi CI; Kim HS; Jang CG; Lee SY
    Arch Pharm Res; 2022 Jun; 45(6):433-445. PubMed ID: 35763157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of
    Chan SW; Chu TTW; Ho CS; Kong APS; Tomlinson B; Zeng W
    Front Med (Lausanne); 2021; 8():683498. PubMed ID: 34568359
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of
    Jung E; Ryu S; Park Z; Lee JG; Yi JY; Seo DW; Lee J; Jeong HS; Kim JM; Oh WY
    J Korean Med Sci; 2018 Jul; 33(27):e182. PubMed ID: 29962926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects.
    Lu S; Nand RA; Yang JS; Chen G; Gross AS
    Eur J Clin Pharmacol; 2018 Mar; 74(3):285-296. PubMed ID: 29181698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Study on CYP2C19 and CYP2D6 Polymorphic Effects on Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Koreans.
    Ryu S; Park S; Lee JH; Kim YR; Na HS; Lim HS; Choi HY; Hwang IY; Lee JG; Park ZW; Oh WY; Kim JM; Choi SE
    Clin Transl Sci; 2017 Mar; 10(2):93-101. PubMed ID: 28296334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics.
    Blake CM; Kharasch ED; Schwab M; Nagele P
    Clin Pharmacol Ther; 2013 Sep; 94(3):394-9. PubMed ID: 23665868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.